Cargando…

Profile of evolocumab and its potential in the treatment of hyperlipidemia

Despite the proven efficacy of statins, they often fail to achieve low-density lipoprotein (LDL) cholesterol goals, especially in high-risk patients. Moreover, a large number of subjects cannot tolerate statins or full doses of these drugs, in particular patients with familial hypercholesterolemia....

Descripción completa

Detalles Bibliográficos
Autores principales:	Cicero, Arrigo FG, Colletti, Alessandro, Borghi, Claudio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4474387/ https://www.ncbi.nlm.nih.gov/pubmed/26109850 http://dx.doi.org/10.2147/DDDT.S67498

Ejemplares similares

Retargeting the management of hypercholesterolemia – focus on evolocumab
por: Colletti, Alessandro, et al.
Publicado: (2016)

Sudden Fall in the Lipid-Lowering Effect of Evolocumab: The Butler Is Not Always Guilty
por: Fogacci, Federica, et al.
Publicado: (2021)

Sudden Fall in the Lipid-Lowering Effect of Evolocumab: The Butler Is Not Always Guilty
por: Fogacci, Federica, et al.
Publicado: (2021)

PCSK9 inhibition in the management of hyperlipidemia: focus on evolocumab
por: Blom, Dirk J, et al.
Publicado: (2016)

Short-term evolocumab-induced tendon xanthomas regression in an elderly patient with homozygous familial hypercholesterolemia
por: Cicero, Arrigo F. G., et al.
Publicado: (2022)

Clinical utility of evolocumab in the management of hyperlipidemia: patient selection and follow-up
por: Dixon, Dave L, et al.
Publicado: (2017)

Fixed combination of zofenopril plus hydrochlorothiazide in the management of hypertension: a review of available data
por: Borghi, Claudio, et al.
Publicado: (2006)

Omega-3 polyunsaturated fatty acids: Their potential role in blood pressure prevention and management
por: BORGHI, CLAUDIO, et al.
Publicado: (2006)

Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients with Mixed Hyperlipidemia
por: Rosenson, Robert S., et al.
Publicado: (2016)

Effects of early treatment with zofenopril in patients with myocardial infarction and metabolic syndrome: the SMILE Study
por: Borghi, Claudio, et al.
Publicado: (2008)

Systematic Review and Network Meta‐Analysis on the Efficacy of Evolocumab and Other Therapies for the Management of Lipid Levels in Hyperlipidemia
por: Toth, Peter P., et al.
Publicado: (2017)

Nutraceutical Approach to Chronic Osteoarthritis: From Molecular Research to Clinical Evidence
por: Colletti, Alessandro, et al.
Publicado: (2021)

Effect of PCSK9 inhibition with evolocumab on lipoprotein subfractions in familial dysbetalipoproteinemia (type III hyperlipidemia)
por: Waldmann, Elisa, et al.
Publicado: (2022)

Real-World Insights Into Evolocumab Use in Patients With Hyperlipidemia: Canadian Analysis From the ZERBINI Study
por: Gupta, Milan, et al.
Publicado: (2022)

Activity and potential role of licofelone in the management of osteoarthritis
por: Cicero, Arrigo FG, et al.
Publicado: (2007)

Misinterpreting data in lipidology in the era of COVID-19
por: Fogacci, Federica, et al.
Publicado: (2020)

The Possible Role of Probiotic Supplementation in Inflammation: A Narrative Review
por: Colletti, Alessandro, et al.
Publicado: (2023)

Effects of a Combined Nutraceutical on Lipid Pattern, Glucose Metabolism and Inflammatory Parameters in Moderately Hypercholesterolemic Subjects: A Double-blind, Cross-over, Randomized Clinical Trial
por: Cicero, Arrigo Francesco Giuseppe, et al.
Publicado: (2016)

A Randomized, Double-Blinded, Placebo-Controlled, Clinical Study of the Effects of a Nutraceutical Combination (LEVELIP DUO(®)) on LDL Cholesterol Levels and Lipid Pattern in Subjects with Sub-Optimal Blood Cholesterol Levels (NATCOL Study)
por: Cicero, Arrigo F.G., et al.
Publicado: (2020)

Nutraceutical Approach to Non-Alcoholic Fatty Liver Disease (NAFLD): The Available Clinical Evidence
por: Cicero, Arrigo F. G., et al.
Publicado: (2018)

Treatment with PCSK9 Inhibitor Evolocumab Improves Vascular Oxidative Stress and Arterial Stiffness in Hypercholesterolemic Patients with High Cardiovascular Risk
por: Silla, Alessia, et al.
Publicado: (2023)

Application of polyunsaturated fatty acids in internal medicine: beyond the established cardiovascular effects
por: Cicero, Arrigo F.G, et al.
Publicado: (2012)

Uric Acid and Hypertension: Prognostic Role and Guide for Treatment
por: Piani, Federica, et al.
Publicado: (2021)

Coenzyme Q(10): Clinical Applications in Cardiovascular Diseases
por: Martelli, Alma, et al.
Publicado: (2020)

Do the Lactotripeptides Isoleucine–Proline–Proline and Valine–Proline–Proline Reduce Systolic Blood Pressure in European Subjects? A Meta-Analysis of Randomized Controlled Trials
por: Cicero, Arrigo F.G., et al.
Publicado: (2013)

An evidence-based review on urate-lowering treatments: implications for optimal treatment of chronic hyperuricemia
por: Bove, Marilisa, et al.
Publicado: (2017)

Therapeutic Strategies for the Treatment of Chronic Hyperuricemia: An Evidence-Based Update
por: Cicero, Arrigo F. G., et al.
Publicado: (2021)

Nutraceuticals as Modulators of Immune Function: A Review of Potential Therapeutic Effects
por: Medoro, Alessandro, et al.
Publicado: (2023)

Nutraceutical Effects on Glucose and Lipid Metabolism in Patients with Impaired Fasting Glucose: A Pilot, Double-Blind, Placebo-Controlled, Randomized Clinical Trial on a Combined Product
por: Cicero, Arrigo Francesco Giuseppe, et al.
Publicado: (2017)

Clinical considerations preliminary to application of the Italian Society for the Study of Headache's guidelines regarding migraine prophylactic treatment
por: Sternieri, Emilio, et al.
Publicado: (2003)

A prospective evaluation of persistence on antihypertensive treatment with different antihypertensive drugs in clinical practice
por: Veronesi, Maddalena, et al.
Publicado: (2007)

Coenzyme Q(10): Clinical Applications beyond Cardiovascular Diseases
por: Testai, Lara, et al.
Publicado: (2021)

Clinical Evaluation Of Evolocumab For The Treatment Of Homozygous Familial Hypercholesterolemia In Chinese Patients
por: Huang, Chin-Chou, et al.
Publicado: (2019)

Multizonal observational study conducted by clinical practitioners on evolocumab use in subjects with hyperlipidemia in Saudi Arabia and Kuwait: Results from the ZERBINI study
por: Al Faraidy, Khalid, et al.
Publicado: (2023)

Influence of metabolic syndrome superposition on familial combined hyperlipoproteinemia cardiovascular complication rate
por: Cicero, Arrigo F.G., et al.
Publicado: (2013)

Effects of Evolocumab on Cardiovascular Events
por: Mikhail, Nasser
Publicado: (2017)

Purine Metabolism Dysfunctions: Experimental Methods of Detection and Diagnostic Potential
por: Cicero, Arrigo F. G., et al.
Publicado: (2023)

Highly Active Cranberry’s Polyphenolic Fraction: New Advances in Processing and Clinical Applications
por: Colletti, Alessandro, et al.
Publicado: (2021)

Advances in Technologies for Highly Active Omega-3 Fatty Acids from Krill Oil: Clinical Applications
por: Colletti, Alessandro, et al.
Publicado: (2021)

Effect of Omega-3 Polyunsaturated Fatty Acids Treatment on Lipid Pattern of HIV Patients: A Meta-Analysis of Randomized Clinical Trials
por: Fogacci, Federica, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0v5f9872tcf5sa7iheh3d9orb1